Effect of antibiotic use on outcomes in patients with Hodgkin lymphoma treated with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Effect of antibiotic use on outcomes in patients with Hodgkin lymphoma treated with immune checkpoint inhibitors

Published:2020-10-06 Issue:1 Volume:62 Page:247-251
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Hwang Steven R.¹^ORCID,Higgins Alexandra²^ORCID,Castillo Almeida Natalia E.³^ORCID,LaPlant Betsy⁴,Maurer Matthew J.⁴^ORCID,Ansell Stephen M.²,Witzig Thomas E.²^ORCID,Thanarajasingam Gita²^ORCID,Bennani N. Nora²^ORCID

Affiliation:

1. Department of Medicine, Mayo Clinic, Rochester, MN, USA

2. Division of Hematology, Mayo Clinic, Rochester, MN, USA

3. Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA

4. Department of Biostatistics, Mayo Clinic, Rochester, MN, USA

Funder

Mayo Clinic Lymphoma Database

University of Iowa/Mayo Clinic Lymphoma SPORE CA97274

Predolin Foundation

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1827250

Reference16 articles.

1. The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment

2. Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies

3. Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial

4. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

5. Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review;Biomedicines;2023-06-15

2. A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors;Frontiers in Oncology;2023-03-02

3. Defining the Role of the Gut Microbiome in the Pathogenesis and Treatment of Lymphoid Malignancies;International Journal of Molecular Sciences;2023-01-24

4. Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma;Leukemia & Lymphoma;2022-10-11

5. The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors;Frontiers in Immunology;2022-07-28